Stock CRDL CARDIOL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cardiol Therapeutics Inc.

Equities

CRDL

CA14161Y2006

Delayed Toronto S.E.
Other stock markets
 10:05:21 2024-04-29 EDT 		5-day change 1st Jan Change
2.46 CAD +0.41% Intraday chart for Cardiol Therapeutics Inc. +1.23% +124.55%
04-22 HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target MT
04-01 Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target
MT
Canaccord Genuity Adjusts Price Target on Cardiol Therapeutics to $6 From $5, Maintains Buy Rating
MT
Cantor Fitzgerald Lowers Price Target to Cardiol Therapeutics to $5 From $6, Maintains Overweight Rating
MT
CARDIOL THERAPEUTICS : Raymond James Adjusts Cardiol Therapeutics PT to CA$5 From CA$4.50, Maintains Outperform Rating
MT
CARDIOL THERAPEUTICS : Target Increased to $5 at Raymond James
MT
CARDIOL THERAPEUTICS : Upgraded to Outperform at Raymond James as First Patient Enrolled in Clinical Trial
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRDL Stock
  4. News Cardiol Therapeutics Inc.
  5. Analyst Reco.